0001493152-21-012688.txt : 20210524
0001493152-21-012688.hdr.sgml : 20210524
20210524160537
ACCESSION NUMBER: 0001493152-21-012688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLETCHER R JOHN
CENTRAL INDEX KEY: 0001215024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35817
FILM NUMBER: 21954849
MAIL ADDRESS:
STREET 1: C/O VYANT BIO, INC.
STREET 2: 201 ROUTE 17 NORTH, 2ND FLOOR
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vyant Bio, Inc.
CENTRAL INDEX KEY: 0001349929
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 043462475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2370 STATE ROUTE 70 WEST
STREET 2: SUITE 310
CITY: CHERRY HILL,
STATE: NJ
ZIP: 08002
BUSINESS PHONE: 201.528.9200
MAIL ADDRESS:
STREET 1: 2370 STATE ROUTE 70 WEST
STREET 2: SUITE 310
CITY: CHERRY HILL,
STATE: NJ
ZIP: 08002
FORMER COMPANY:
FORMER CONFORMED NAME: CANCER GENETICS, INC
DATE OF NAME CHANGE: 20111216
FORMER COMPANY:
FORMER CONFORMED NAME: CANCER GENETICS INC
DATE OF NAME CHANGE: 20060117
4
1
ownership.xml
X0306
4
2021-05-21
0
0001349929
Vyant Bio, Inc.
VYNT
0001215024
FLETCHER R JOHN
C/O VYANT BIO, INC. 2 EXECUTIVE CAMPUS
2370 STATE ROUTE 70, SUITE 310
CHERRY HILL,
NJ
08002
1
0
0
0
Common Stock, $0.0001 par value
2021-05-21
4
P
0
15000
3.3299
A
15000
I
By R. John Fletcher 2015 Revocable Trust
Common Stock, $0.0001 par value
2021-05-24
4
P
0
15300
3.3879
A
30300
I
By R. John Fletcher 2015 Revocable Trust
Common Stock, $0.0001 par value
8676
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.31 to $3.34 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.47 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
/s/ Andrew LaFrence, attorney-in-fact
2021-05-24